Emmes

Executive Summary

Emmes is a full-service clinical research organization (CRO) headquartered in Rockville, Maryland, with a legacy spanning nearly five decades since its founding in 1977. The company supports biopharmaceutical, government, non-profit, and academic partners in achieving their development and human health goals. Emmes differentiates itself by integrating technology and artificial intelligence across all clinical functions, aiming to deliver programs faster, more efficiently, and with higher quality. This end-to-end use of AI positions Emmes as a forward-looking CRO in an increasingly digital clinical trial landscape. As a private entity, Emmes maintains a low profile but has built a reputation for reliability and innovation in clinical research.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation AI Clinical Platform70% success
• Q4 2026Major Government or Biopharma Contract Win65% success
• H1 2027Potential Strategic Acquisition or Partnership50% success